Biochemistry and genetics of von Willebrand factor
- PMID: 9759493
- DOI: 10.1146/annurev.biochem.67.1.395
Biochemistry and genetics of von Willebrand factor
Abstract
Von Willebrand factor (VWF) is a blood glycoprotein that is required for normal hemostasis, and deficiency of VWF, or von Willebrand disease (VWD), is the most common inherited bleeding disorder. VWF mediates the adhesion of platelets to sites of vascular damage by binding to specific platelet membrane glycoproteins and to constituents of exposed connective tissue. These activities appear to be regulated by allosteric mechanisms and possibly by hydrodynamic shear forces. VWF also is a carrier protein for blood clotting factor VIII, and this interaction is required for normal factor VIII survival in the circulation. VWF is assembled from identical approximately 250 kDa subunits into disulfide-linked multimers that may be > 20,000 kDa. Mutations in VWD can disrupt this complex biosynthetic process at several steps to impair the assembly, intracellular targeting, or secretion of VWF multimers. Other VWD mutations impair the survival of VWF in plasma or the function of specific ligand binding sites. This growing body of information about VWF synthesis, structure, and function has allowed the reclassification of VWD based upon distinct pathophysiologic mechanisms that appear to correlate with clinical symptoms and the response to therapy.
Similar articles
-
Molecular genetics of von Willebrand disease.Ann Genet. 1998;41(1):34-43. Ann Genet. 1998. PMID: 9599650 Review.
-
Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.Acta Haematol. 2009;121(2-3):128-38. doi: 10.1159/000214853. Epub 2009 Jun 8. Acta Haematol. 2009. PMID: 19506359 Review.
-
Laboratory diagnosis and molecular classification of von Willebrand disease.Acta Haematol. 2009;121(2-3):71-84. doi: 10.1159/000214846. Epub 2009 Jun 8. Acta Haematol. 2009. PMID: 19506352 Review.
-
Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.Clin Appl Thromb Hemost. 2006 Jul;12(3):277-95. doi: 10.1177/1076029606291401. Clin Appl Thromb Hemost. 2006. PMID: 16959681 Review.
-
Molecular mechanism and classification of von Willebrand disease.Thromb Haemost. 1995 Jul;74(1):161-6. Thromb Haemost. 1995. PMID: 8578450 Review.
Cited by
-
Increased active von Willebrand factor during disease development in the aging diabetic patient population.Age (Dordr). 2013 Feb;35(1):171-7. doi: 10.1007/s11357-011-9335-0. Epub 2011 Nov 27. Age (Dordr). 2013. PMID: 22120183 Free PMC article.
-
VWF, Platelets and the Antiphospholipid Syndrome.Int J Mol Sci. 2021 Apr 18;22(8):4200. doi: 10.3390/ijms22084200. Int J Mol Sci. 2021. PMID: 33919627 Free PMC article. Review.
-
Plasma Level of von Willebrand Factor Propeptide at Diagnosis: A Marker of Subsequent Renal Dysfunction in Autoimmune Rheumatic Diseases.Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620938874. doi: 10.1177/1076029620938874. Clin Appl Thromb Hemost. 2020. PMID: 32705883 Free PMC article.
-
pH-Dependent Interactions in Dimers Govern the Mechanics and Structure of von Willebrand Factor.Biophys J. 2016 Jul 26;111(2):312-322. doi: 10.1016/j.bpj.2016.06.022. Biophys J. 2016. PMID: 27463134 Free PMC article.
-
The important role of von Willebrand factor in platelet-derived FVIII gene therapy for murine hemophilia A in the presence of inhibitory antibodies.J Thromb Haemost. 2015 Jul;13(7):1301-9. doi: 10.1111/jth.13001. Epub 2015 Jun 11. J Thromb Haemost. 2015. PMID: 25955153 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous